NEXT

The Recorder

Lawyers for Thernaos' Elizabeth Holmes Ask to Push Back Trial Until April Amid COVID-19 Concerns

"I'm sitting in the ceremonial courtroom alone, and I look out and try to envision what a jury trial for three months would look like here, maybe 12 jurors and 5 alternates, maybe more," said U.S. District Judge Edward Davila, as parties in the federal case against Elizabeth Holmes work to pinpoint a trial date that's safe in light of the coronavirus pandemic.
5 minute read

New York Law Journal

Latham Strikes Again on Branded Pharma by Adding 2 Hogan Lovells Litigators

The firm adds Hogan Lovells Arlene Chow and Ernest Yakob in New York five months after landing the co-chair of Williams & Connolly's patent group. All represent innovators in the pharmaceutical and biologic drug space.
5 minute read

National Law Journal

How AbbVie and Humira Avoided 'Pay for Delay' Finding

The company's agreement to trade biosimilar competitors' earlier market entry in Europe for lengthier exclusivity in the U.S. does not run afoul of the Supreme Court's Actavis decision, U.S. District Judge Manish Shah ruled Monday.
3 minute read

The Recorder

Federal Circuit Called on Once Again to Judge the 'Patent Dance'

Genentech is looking to block sales of Amgen's cancer biosimilar Mvasi because Amgen failed to provide 180 days' notice when it shifted manufacturing plans from California to Rhode Island. Judge Kimberly Moore said Genentech is proposing "an extraordinarily broad view" of the Biologics Price Competition and Innovation Act.
4 minute read

The Recorder

The Data Room in Patent Due Diligence: Perspectives from Two Doors

Putting yourself at the threshold of the other door and considering the room from that perspective can provide useful reminders of each side's strategic opportunities and concerns, and ensure that the doors to the deal are kept open.
7 minute read

The Recorder

Prosecutors Defend Decision to Add Charges in Case Against Elizabeth Holmes by Information, Rather Than Indictment

Lawyers for Theranos founder Elizabeth Holmes had argued in a motion filed earlier this month that a superseding information prosecutors filed without grand jury sign-off should be dismissed, because she has not waived the right to be charged by indictment.
3 minute read

Corporate Counsel

Pharma Firm General Counsel on How Risk, Flexibility Delivered 'Home Run' With COVID-19 Drug

"Lawyers, in my personal view and to over-generalize, can be a little too risk-averse," said Ligand's longtime general counsel, Charles Berkman.
4 minute read

Daily Report Online

Atlanta Lawyers Eye Trials of COVID-19 Drug After 'Mad Scramble' for IP Deal

A typical intellectual property transaction licensing a drug to a producer might take four to six months. The deal for Emory University's potential treatment for COVID-19 took two weeks.
5 minute read

New York Law Journal

Investor Suit Targets NY Firm Over COVID-19 Test Kit Deal

A new securities class action, filed Wednesday in Manhattan federal court, accused New York City-based healthcare logistics firm SCWorx Corp. of misleading investors about a supposed deal to buy and resell millions of COVID-19 rapid testing kits.
3 minute read

Resources

  • Aligning Client Needs with Lawyer Growth and Profitability

    Brought to you by BigHand

    Download Now

  • Technology to Make E-Discovery Smarter, Not Harder

    Brought to you by Nuix

    Download Now

  • Does Generative AI Have the Power to Transform Legal Services?

    Brought to you by HaystackID

    Download Now

  • How This Personal Injury Firm Reduced Client Intake Time by 80%

    Brought to you by PracticePanther

    Download Now